Ecolab sees 2H EPS to ‘normalize’ to upper-end of 12-15% LT target

Quarterly adjusted diluted earnings per share growth in the second half of 2024 is expected to progressively normalize towards the upper-end of Ecolab’s long-term 12-15% target as favorability from lower delivered product costs eases. The company currently expects quantifiable special charges in 2024 to be approximately 15c per share, principally related to restructuring charges. This does not include the expected gain on the sale of the company’s global surgical solutions business. Other than the special gains and charges noted above, other such amounts are not currently quantifiable.